[go: up one dir, main page]

Padgette et al., 1984 - Google Patents

Antihypertensive activities of phenyl aminoethyl sulfides, a class of synthetic substrates for dopamine. beta.-hydroxylase

Padgette et al., 1984

Document ID
8896644289240579601
Author
Padgette S
Herman H
Han J
Pollock S
May S
Publication year
Publication venue
Journal of medicinal chemistry

External Links

Snippet

Four sulfur-containing analogues of phenylpropylamine were synthesized and evaluated as substrates for dopamine ß-hydroxylase (DBH) and monoamine oxidase (MAO). All four phenyl aminoethyl sulfides were shown to be good substrates for DBH whereas only the two …
Continue reading at pubs.acs.org (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids

Similar Documents

Publication Publication Date Title
Padgette et al. Antihypertensive activities of phenyl aminoethyl sulfides, a class of synthetic substrates for dopamine. beta.-hydroxylase
RU2084453C1 (en) Method of synthesis of aromatic derivatives or their salts with organic or inorganic acids or their racemates
KR880000042B1 (en) Process for preparing organic amide compounds derived from nitrogenous lipoids
Subasinghe et al. Quisqualic acid analogs: synthesis of. beta.-heterocyclic 2-aminopropanoic acid derivatives and their activity at a novel quisqualate-sensitized site
EP0487620B1 (en) Novel amino acid derivatives, method for preparing them, and their therapeutical applications
EP0082088A1 (en) Derivatives of amino acids and their therapeutic use
WO1994015955A1 (en) Thiazolidine derivatives, preparation thereof and drugs containing same
LU80596A1 (en) SUBSTITUTED AMIDES OF L- AND DL-PHENYLGLYCIN, THEIR PRODUCTION PROCESS AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
Jaiswal et al. Scaffold hopping-guided design of some isatin based rigid analogs as fatty acid amide hydrolase inhibitors: Synthesis and evaluation
EP2681209B1 (en) Compounds and methods for the treatment of pain and other disorders
EP0218622A1 (en) AMIDES OF PARA-METHOXYCINNAMIC ACID AND THEIR USE AS SOLAR FILTERS.
EP0947503B1 (en) 6,8-Dimethylmercaptooctanoic acid derivatives substituted on 6-S and/or 8-S by the 3-methylthiopropanoyl radical and pharmaceutical compositions for the treatment of cancerous tumours
Wong et al. Selective effects of N-acetylcysteine stereoisomers on hepatic glutathione and plasma sulfate in mice
KR20060088885A (en) Neuropathic pain treatment method using an agonist of neuropeptide FF receptor 2
Jia et al. Physicochemistry, pharmacokinetics, and pharmacodynamics of S‐nitrosocaptopril crystals, a new nitric oxide donor
EP1022029A1 (en) Nootropic agent
FR2493311A1 (en) 2,6-C-DIMETHYLTYROSIN1- (D-AMINOACIDIC) 2- (E-AMINO-CAPROIC ACID AND G-AMINOBUTYRIC ACID) 5 OF METHIONINE-ENCEPHALINE, USEFUL AS ANALGESICS
DE69420345T2 (en) BENZOTHIAZOLESULFONAMIDE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND APPLICATIONS
Mosley et al. Synthesis, structural activity-relationships, and biological evaluation of novel amide-based allosteric binding site antagonists in NR1A/NR2B N-methyl-D-aspartate receptors
US4371539A (en) CNS Stimulants
Béguin et al. Functionalized amido ketones: new anticonvulsant agents
FI81794B (en) FOERFARANDE FOER FRAMSTAELLNING AV THERAPEUTISKT ANVAENDBAR ALLYLAMIN.
Sparks et al. Metaldehyde molluscicide action in mice: distribution, metabolism, and possible relation to GABAergic system
Wolf et al. Combined histamine H1/H2 receptor antagonists: Part II.: Pharmacological hybrids with pheniramine-and tiotidine-like substructures
JP4189029B2 (en) Use of unsubstituted and substituted N- (pyrrol-1-yl) pyridinamines as anticonvulsants